Voyager Therapeutics Inc. (VYGR)
3.42
0.05 (1.48%)
At close: Apr 02, 2025, 3:59 PM
3.38
-1.17%
After-hours: Apr 02, 2025, 07:55 PM EDT
Voyager Therapeutics Ratios Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
| PE Ratio | -5.03 | 2.74 | -5.04 | -1.55 | 7.23 | -12.26 | -3.41 | -6.29 | -8.02 | -3.09 | -16.01 | -1.07 |
| PEG Ratio | 0.04 | -0.01 | 0.16 | 0.01 | -0.04 | 0.21 | -0.82 | -0.1 | 0.10 | -0.01 | 0.17 | n/a |
| PS Ratio | 4.09 | 1.45 | 5.72 | 2.73 | 1.55 | 4.80 | 39.56 | 43.90 | 22.67 | 5.30 | n/a | n/a |
| PB Ratio | 1.09 | 1.54 | 3.96 | 1.07 | 1.72 | 5.03 | 6.49 | 3.32 | 2.37 | 0.54 | 227.29 | -2.14 |
| P/FCF Ratio | -17.36 | 4.86 | -15.6 | -1.85 | -2.44 | 12.23 | -14.93 | -6.81 | -6.78 | 2.28 | -17.52 | -1.51 |
| P/OCF Ratio | -21.36 | 4.66 | -18.7 | -1.91 | -2.75 | 10.29 | -18.97 | -7.25 | -7.59 | 2.22 | -21.91 | -1.51 |
| OCF/S Ratio | -0.19 | 0.31 | -0.31 | -1.43 | -0.57 | 0.47 | -2.09 | -6.05 | -2.99 | 2.38 | n/a | n/a |
| Debt / Equity Ratio | 0.15 | 0.09 | 0.39 | 0.46 | 0.31 | 0.34 | n/a | n/a | n/a | n/a | 5.49 | -0.76 |
| Quick Ratio | 5.56 | 4.96 | 1.70 | 2.65 | 7.13 | 3.98 | 4.97 | 10.69 | 12.84 | 9.41 | 3.38 | 0.03 |
| Current Ratio | 5.56 | 4.96 | 1.72 | 2.68 | 7.39 | 4.01 | 5.13 | 10.81 | 12.95 | 8.19 | 3.38 | 0.03 |
| Asset Turnover | 0.20 | 0.71 | 0.26 | 0.19 | 0.65 | 0.29 | 0.04 | 0.05 | 0.08 | 0.08 | n/a | n/a |
| Interest Coverage | n/a | n/a | -28.37 | n/a | n/a | n/a | n/a | n/a | -42.31 | -61.01 | n/a | n/a |
| Return on Equity | -0.22 | 0.56 | -0.79 | -0.69 | 0.24 | -0.41 | -1.9 | -0.53 | -0.3 | -0.18 | -14.2 | 2.00 |
| Return on Assets | -0.17 | 0.38 | -0.29 | -0.34 | 0.14 | -0.12 | -0.5 | -0.38 | -0.21 | -0.13 | -1.42 | -51.45 |
| Return on Invested Capital | -0.24 | 0.42 | -0.57 | -0.46 | 0.12 | -0.17 | -0.63 | -0.42 | -0.24 | -0.1 | -1.59 | 8.17 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 1.00 | 0.98 | 0.85 | -0.97 | 0.36 | -0.15 | -7.52 | -5.14 | -1.97 | -0.6 | n/a | n/a |
| Net Profit Margin | -0.81 | 0.53 | -1.13 | -1.76 | 0.21 | -0.39 | -11.59 | -6.98 | -2.83 | -1.71 | n/a | n/a |
| Pretax Profit Margin | -0.8 | 0.53 | -1.13 | -1.9 | 0.21 | -0.42 | -11.61 | -6.98 | -2.82 | -1.71 | n/a | n/a |
| Operating Profit Margin | -1.04 | 0.49 | -1.24 | -1.97 | 0.16 | -0.5 | -11.96 | -7.09 | -2.9 | -1.17 | n/a | n/a |
| FCF Margin | -23.54 | 29.86 | -36.67 | -147.36 | -63.59 | 39.23 | -265.02 | -644.65 | -334.11 | 232.31 | n/a | n/a |
| EBITDA Margin | -1.04 | 0.51 | -1.09 | -1.83 | 0.18 | -0.47 | -11.68 | -6.93 | -2.86 | -1.13 | n/a | n/a |